INTERNATIONAL PATENT: MODERNATX, INC., MERCK SHARP & DOHME LLC FILES APPLICATION FOR "INDIVIDUALIZED NEOANTIGEN VACCINES FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER"

GENEVA, March 31 -- MODERNATX, INC. (325 Binney StreetCAMBRIDGE, Massachusetts 02142), MERCK SHARP & DOHME LLC (126 East Lincoln AvenueRahway, New Jersey 07065) filed a patent application (PCT/US2025/046733) for "INDIVIDUALIZED NEOANTIGEN VACCINES FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER" on Sep 17, 2025. With publication no. WO/2026/064370, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BROWN, Michelle (c/o ModernaTX, Inc., 325 Binney StreetCambridge, Massachusetts 02141), BANERJEE, Joydeep (c/o ModernaTX, Inc., ...